Cipla gains on launching antibody detection kits for COVID-19 in India

29 Oct 2020 Evaluate

Cipla is currently trading at Rs. 770.50, up by 5.35 points or 0.70% from its previous closing of Rs. 765.15 on the BSE.

The scrip opened at Rs. 766.10 and has touched a high and low of Rs. 773.20 and Rs. 757.15 respectively. So far 36410 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 829.00 on 13-Oct-2020 and a 52 week low of Rs. 356.75 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 779.50 and Rs. 742.50 respectively. The current market cap of the company is Rs. 61658.76 crore.

The promoters holding in the company stood at 36.70%, while Institutions and Non-Institutions held 39.82% and 23.48% respectively.

Cipla has launched antibody detection kits for COVID-19 in India under the brand name 'ELIFast' in partnership with KARWA, under the technology transfer from the Indian Council of Medical Research (ICMR). As part of the collaborative effort, the company will be responsible for the marketing and distribution of the SARS CoV-2-IgG antibody detection ELISA that will be manufactured by KARWA.

ICMR has provided the requisite technological know-how and process for developing the test kits to the approved manufacturers. The company's distribution network will help in ensuring the seamless supply of kits across the country. Supply will be undertaken through the channels approved by ICMR to ensure equitable access.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1497.45 -23.10 (-1.52%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×